Core Viewpoint - Six ST/*ST stocks will be "delisted" and resume trading on May 20, indicating improved financial conditions and compliance with regulatory requirements [2][4]. Group 1: Stocks Resuming Trading - ST Aonong (603363) will have its delisting risk warning removed and will resume trading with a new name "Aonong Biological" on May 20. The company reported a net asset of 2.566 billion yuan and a revenue of 8.763 billion yuan for 2024, with a net profit of 579 million yuan [5]. - ST Mingjia (300506) will continue to have other risk warnings but will resume trading under the name "ST Mingjia Hui." The company reported a revenue of 117 million yuan for 2024, with a net asset of 96.44 million yuan [6]. - ST Kexin (600234) will also have its delisting risk warning removed and will resume trading as "Kexin Development" [7]. - ST Zhongtai (002092), ST Shengda (002259), and ST Muyao (600671) will remove other risk warnings and resume trading with new names: "Zhongtai Chemical," "Shengda Forestry," and "Tianmu Pharmaceutical," respectively [8]. Group 2: Major Asset Restructuring Announcements - Huibo Yuntong and Xinbang Intelligent will resume trading on May 20 after announcing major asset restructuring plans. Xinbang Intelligent plans to acquire control of Wuxi Yingdixin Microelectronics through a combination of share issuance and cash payments [12][13]. - Huibo Yuntong intends to acquire 67.91% of Baode Computer Systems through share issuance and cash payments, aiming to enhance its competitive edge in the IT infrastructure sector [13].
多只A股,“摘星脱帽”,周二复牌
证券时报·2025-05-19 15:30